Cogstate Limited
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, includ… Read more
Cogstate Limited (COGZF) - Net Assets
Latest net assets as of June 2025: $47.90 Million USD
Based on the latest financial reports, Cogstate Limited (COGZF) has net assets worth $47.90 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($64.77 Million) and total liabilities ($16.88 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $47.90 Million |
| % of Total Assets | 73.95% |
| Annual Growth Rate | 32.89% |
| 5-Year Change | 119.88% |
| 10-Year Change | 247.21% |
| Growth Volatility | 106.66 |
Cogstate Limited - Net Assets Trend (2014–2025)
This chart illustrates how Cogstate Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cogstate Limited (2014–2025)
The table below shows the annual net assets of Cogstate Limited from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $47.90 Million | +17.36% |
| 2024-06-30 | $40.81 Million | +8.29% |
| 2023-06-30 | $37.69 Million | +14.48% |
| 2022-06-30 | $32.92 Million | +51.13% |
| 2021-06-30 | $21.78 Million | -7.31% |
| 2020-06-30 | $23.50 Million | +62.98% |
| 2019-06-30 | $14.42 Million | -8.79% |
| 2018-06-30 | $15.81 Million | +9.78% |
| 2017-06-30 | $14.40 Million | +4.39% |
| 2016-06-30 | $13.79 Million | +36.38% |
| 2015-06-30 | $10.11 Million | +382.13% |
| 2014-06-30 | $2.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cogstate Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 778501852.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $5.76 Million | 12.04% |
| Other Components | $42.13 Million | 87.96% |
| Total Equity | $47.90 Million | 100.00% |
Cogstate Limited Competitors by Market Cap
The table below lists competitors of Cogstate Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Puravankara Limited
NSE:PURVA
|
$82.55 Million |
|
Garda Property Group
AU:GDF
|
$82.58 Million |
|
RTX A/S
CO:RTX
|
$82.60 Million |
|
Apogee Optocom Co Ltd
TW:6426
|
$82.64 Million |
|
Leifheit AG
LSE:0F2Z
|
$82.54 Million |
|
Allianz Ayudhya Capital Public Company Limited
BK:AYUD
|
$82.53 Million |
|
La Opala RG Limited
NSE:LAOPALA
|
$82.53 Million |
|
Raisio Oyj
HE:RAIKV
|
$82.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cogstate Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 40,921,807 to 47,897,815, a change of 6,976,008 (17.0%).
- Net income of 10,144,735 contributed positively to equity growth.
- Share repurchases of 4,837,068 reduced equity.
- New share issuances of 1,154,547 increased equity.
- Other factors increased equity by 513,794.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $10.14 Million | +21.18% |
| Share Repurchases | $4.84 Million | -10.1% |
| Share Issuances | $1.15 Million | +2.41% |
| Other Changes | $513.79K | +1.07% |
| Total Change | $- | 17.05% |
Book Value vs Market Value Analysis
This analysis compares Cogstate Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.10x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-06-30 | $0.00 | $0.88 | x |
| 2017-06-30 | $0.13 | $0.88 | x |
| 2018-06-30 | $0.14 | $0.88 | x |
| 2019-06-30 | $0.12 | $0.88 | x |
| 2020-06-30 | $0.14 | $0.88 | x |
| 2021-06-30 | $0.13 | $0.88 | x |
| 2022-06-30 | $0.19 | $0.88 | x |
| 2023-06-30 | $0.22 | $0.88 | x |
| 2024-06-30 | $0.24 | $0.88 | x |
| 2025-06-30 | $0.28 | $0.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cogstate Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.18%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.97%
- • Asset Turnover: 0.78x
- • Equity Multiplier: 1.35x
- Recent ROE (21.18%) is above the historical average (-1.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -29.88% | -34.33% | 0.75x | 1.16x | $-836.57K |
| 2015 | -50.05% | -31.49% | 1.12x | 1.41x | $-6.07 Million |
| 2016 | 19.15% | 9.69% | 1.39x | 1.42x | $1.26 Million |
| 2017 | -5.72% | -2.36% | 1.60x | 1.51x | $-2.26 Million |
| 2018 | -4.84% | -1.95% | 1.54x | 1.61x | $-2.35 Million |
| 2019 | -24.68% | -11.43% | 1.13x | 1.90x | $-5.00 Million |
| 2020 | -8.16% | -5.56% | 0.75x | 1.96x | $-4.27 Million |
| 2021 | 24.02% | 16.01% | 0.64x | 2.36x | $3.05 Million |
| 2022 | 22.84% | 16.72% | 0.77x | 1.78x | $4.23 Million |
| 2023 | 9.47% | 8.82% | 0.75x | 1.43x | $-201.12K |
| 2024 | 13.32% | 12.55% | 0.75x | 1.41x | $1.36 Million |
| 2025 | 21.18% | 19.97% | 0.78x | 1.35x | $5.35 Million |
Industry Comparison
This section compares Cogstate Limited's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cogstate Limited (COGZF) | $47.90 Million | -29.88% | 0.35x | $82.54 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |